A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body’s immune response ...

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...

particularly non-small cell lung cancer (NSCLC) and pancreatic cancer, according to results from a phase II study. Among 158 evaluable patients with 10 tumor types, 30% had an overall response ...

Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

Researchers have discovered a particular type of cancer cell that relies on its own biological electric utility company to thrive. Disrupting this power plant – with the help of a puffer fish – showed ...

Ocean Biomedical (OCEA) announced newly published research findings demonstrating the ability of its proprietary cancer immunotherapy ...

Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestProvidence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean ...